SEC 13F Intelligence

Managers / Q3 2019 · view latest →

MASO CAPITAL PARTNERS Ltd

CIK 0001698093 · 8/F PRINTING HOUSE, 6 DUDDELL STREET, HONG KONG, 000000 · 852 34686200

Reported Value
$278M
Q3 2019
Positions
19
Filings on Record
30
2019–present window
Filed
Nov 14, 2019
original filing

Summary

Maso Capital Partners Ltd reported $278M in U.S.-listed holdings across 19 positions for Q3 2019.

The portfolio is heavily concentrated: CELG alone accounts for 32.1% of reported value.

Compared with Q2 2019, the fund opened 5 new positions and exited 5.

Portfolio Metrics

Turnover
+22.6%
vs prior filed quarter
Top-10 Concentration
+90.7%
share of reported value
Largest Position
+32.1%
Celgene
New / Exited
5 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $80MQ4 ’18Q1 ’19: $145MQ2 ’19: $191MQ3 ’19: $278MQ4 ’19: $311MQ4 ’19Q1 ’20: $386MQ2 ’20: $248MQ3 ’20: $179MQ4 ’20: $367MQ4 ’20Q1 ’21: $260MQ2 ’21: $304MQ3 ’21: $222MQ4 ’21: $218MQ4 ’21Q1 ’22: $246MQ2 ’22: $177MQ3 ’22: $429MQ1 ’23: $150,581Q1 ’23Q2 ’23: $228,000Q3 ’23: $183,560Q4 ’23: $115,713Q1 ’24: $135,260Q1 ’24Q3 ’24: $107MQ4 ’24: $79MQ1 ’25: $66MQ2 ’25: $57MQ2 ’25Q3 ’25: $61Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 46.5%Other: 24.1%ADR: 18.3%MLP: 11.1%
  • Common Stock · 46.5% · $129M
  • Other · 24.1% · $67M
  • ADR · 18.3% · $51M
  • MLP · 11.1% · $31M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
2663134DBITAUTO HOLDINGS LTDNEW+1.68M1.68M+$25M$25M
ALLERGAN PLCNEW+148.0K148.0K+$25M$25M
GENESEE & WYOMING INCNEW+109.5K109.5K+$12M$12M
NEW FRONTIER CORPNEW+700.0K700.0K+$7M$7M
BABAALIBABA GROUP HLDG LTDNEW+5.1K5.1K+$850,000$850,000
CYOUUSDCHANGYOU COM LTDADDED+1.06M1.62M+$10M$15M
RHT1EURRED HAT INCSOLD OUT191.1K0$36M$0
ALIBABA GROUP HLDG LTDSOLD OUT5000$8M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2019

19 positions
#IssuerClass% PortfolioValueShares
1CELGCELGENE CORPhistory →COM32.07%$89M899.0K
2BPLUSDBUCKEYE PARTNERS LPhistory →UNIT LTD PARTN11.07%$31M749.6K
3CHINA BIOLOGIC PRODS HLDGS ICOM9.19%$26M223.4K
42663134DBITAUTO HOLDINGS LTDhistory →SPONSORED ADS9.01%$25M1.68M
5ALLERGAN PLCSHS8.95%$25M148.0K
6CYOUUSDCHANGYOU COM LTDhistory →ADS REP CL A5.53%$15M1.62M
7GNWGENWORTH FINL INChistory →COM CL A4.45%$12M2.81M
8GENESEE & WYOMING INCCL A4.35%$12M109.5K
9BUNGE LIMITEDCOM3.43%$10M168.4K
10ACHCACADIA HEALTHCARE COMPANY INhistory →COM2.70%$8M242.2K
11NEW FRONTIER CORPCOM CL A2.56%$7M700.0K
12YUMCYUM CHINA HLDGS INChistory →COM2.42%$7M148.1K
13SOHUSOHU COM LTDhistory →SPONSORED ADS1.19%$3M325.7K
14MELCO RESORTS AND ENTMT LTDADR1.01%$3M144.5K
15TAKEDA PHARMACEUTICAL CO LTDSPONSORED ADS0.79%$2M127.8K
16BYNDBEYOND MEAT INCCOM0.52%$1M9.8K
17HCMUSDHUTCHISON CHINA MEDITECH LTDSPONSORED ADR0.44%$1M69.0K
18BABAALIBABA GROUP HLDG LTDSPONSORED ADS0.31%$850,0005.1K
19NAKED BRAND GROUP LIMITEDORD SHS0.03%$72,0002.12M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2025$61M44Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$57M29Aug 18, 202513F-HRchanges · EDGAR ↗
Q1 2025$66M34May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$79M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$107M36Nov 4, 202413F-HRchanges · EDGAR ↗
Q2 2024Under review28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$135,26036May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$115,71327Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$183,56037Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$228,00037Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$150,58136May 11, 202313F-HRchanges · EDGAR ↗
Q4 2022Under review42Feb 13, 202313F-HRchanges · EDGAR ↗
Q3 2022REVEALED$429M60Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$177M61Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$246M56May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$218M47Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M41Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$304M54Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$260M47May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$367M45Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$179M21Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$248M22Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$386M21May 11, 202013F-HRchanges · EDGAR ↗
Q4 2019$311M20Feb 12, 202013F-HRchanges · EDGAR ↗
Q3 2019$278M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$191M19Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$145M16May 14, 201913F-HRchanges · EDGAR ↗
Q4 2018$80M10Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.